Recall Register

Food, drugs, devices › Quidel Corporation

Device recall: QUIDEL InflammaDry MMP-9 Test, REF: PRS-ID-20-U, 20 Tests

FDA enforcement event 94219 · Class II · initiated 5 Mar 2024 · status Ongoing

DeviceVoluntary: Firm initiated2 product recordsSan Diego, CA

Quidel Corporation (San Diego, CA) initiated this device recall on 5 Mar 2024; FDA lists 2 product records under event 94219, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 87% of the 970 device enforcement events initiated in 2024 carry the same class.

Status: Ongoing. Initiation: voluntary: firm initiated. Quidel Corporation has 13 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Quidel Corporation, San Diego, CA.

Reason for recall

"There are two windows on the test device, the control line window and the test results window. The line for the test results window were misaligned. In instances of positive test results, the positivite test line may not be visible/ hidden under the cassette of the test device thus potentially leading to a false negative result."

Distribution

"US: AK AL AR AZ CA CO CT DC FL GA HI IA ID IL IN KS KY LA MA MD MI MN MO MT NC ND NE NH NJ NV NY OH OK OR PA SC SD TN TX UT VA WA WI WV OUS: United Arab Emirates, Belgium, Canada, Chile, China,…"

Product records

Recall numberProductQuantityClassStatusReport date
Z-1636-2024QUIDEL InflammaDry MMP-9 Test, REF: PRS-ID-20-U, 20 Tests104,300 unitsClass IIOngoing1 May 2024
Z-1637-2024QUIDEL InflammaDry MMP-9 Test, REF: PRS-ID-20, 20 Tests31,140 unitsClass IIOngoing1 May 2024

Context

87%of 2024 device events are Class II970 events that year
2product records in this eventfirm median: 1
13events on this register for the firm

Other enforcement events for Quidel Corporation

InitiatedProduct (first record)TypeClassRecords
6 Apr 2026QuickVue Dipstick Strep A Test, 50T, REF 20108, antigens, all groups, streptococcus spp.DeviceClass II1
17 Jun 2025QuickVue: Dipstick Strep A Test: 50T, REF: 20108; 25T, REF: 20125; 50T, SCN, REF: 20108SCDeviceClass II1
3 Jan 2024The Sofia 2 Flu + SARS Antigen FIA employs immunofluorescence technology in a sandwich design that is used with Sofia 2 DeviceClass II1
1 Feb 2023MicroVue C1-Inhibitor Plus EIA for measuring the amount of functional C1-lnhibitor protein in human plasma or serum, CatDeviceClass II1
13 Aug 2021Lyra Direct SARS-CoV-2 Assay Emergency Use Authorization- Ref: M124. The Lyra Direct SARS-CoV-2 Assay is a real-time RT-DeviceClass II1
27 Apr 2021Lyra SARS-CoV-2 Assay (M120) in vitro diagnostic test reagentDeviceClass I1
25 Sep 2020QUIDEL Sofia SARS Antigen FIA IVD REF 20374DeviceClass II1
17 Sep 2020Sofia SARS Antigen FIA Package Insert The Sofia SARS Antigen FIA is a lateral flow immunofluorescent sandwich assay thatDeviceClass II1
15 Dec 2017Sofia 2 Analyzer Catalog Number 20299 Sofia 2 is a bench top analyzer intended to be used with Cassette-based immunofluoDeviceClass II1
22 Jun 2017InflammaDry(R) AN RPS DIAGNOSTIC SOLUTION, Sample Collectors InflammaDry(R) is a rapid, immunoassay test for the visual,DeviceClass II1

All 13 events for Quidel Corporation

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "There are two windows on the test device, the control line window and the test results window. The line for the test results window were misaligned. In instances of positive test results, the positivite test line may not be visible/ hidden under the cassette of the test device thus potentially leading to a false negative result."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "US: AK AL AR AZ CA CO CT DC FL GA HI IA ID IL IN KS KY LA MA MD MI MN MO MT NC ND NE NH NJ NV NY OH OK OR PA SC SD TN TX UT VA WA WI WV OUS: United Arab Emirates, Belgium, Canada, Chile, China,…"

Is the recall still ongoing?

FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.